Daily Stock List
Precision Optics Corp., Inc. (PEYE)
Marketbeat.com, PennyStockScholar, OTCtipReporter, SmallCapInvestorDaily, Pumps and Dumps, Michael Stone, InvestorTrendz, Club Penny Stocks Network, Growing Stocks Reports, Research Driven Investor, and Bull Trends reported on Precision Optics Corp., Inc. (PEYE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Precision Optics Corp., Inc. (utilizing proprietary optical technologies) is a foremost developer and manufacturer of advanced optical instruments. The Company designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions under 1 millimeter, as well as other advanced optical systems for a broad array of customers. Precision Optics has its corporate head office in Gardner, Massachusetts. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Precision Optics’ expertise includes the design, development, and manufacturing of optical and mechanical-optical components, sub-assemblies, and systems. These include lenses, prisms, thin film coatings, optical assemblies, sinuscopes, arthroscopes, laparoscopes, stereo-endoscopes, beamsplitters, endocouplers, camera adapters and fiber optic assemblies.
The Company developed the Cidex™ soakable endocoupler in 1983; developed the first commercially available stereoendoscope; and patented first-rate durability and easy to repair sinuscopes and arthroscopes. It has expertise in providing lenses to sizes as small as 0.2mm in diameter employing its proprietary Microprecision™ technology with the quality of ground lenses approaching the cost of gradient index (GRIN) lenses.
Pertaining to Micro-Optics & Components, the Company has an in-house optical shop, flexible manufacturing, and staff of highly trained optical designers and technicians. It can manufacture cost-effectively in prototype, low or high volumes. Furthermore, Precision Optics provides optical components, optical system design and production of different lens and prism products for the defense industry and aerospace industry.
This past May, Precision Optics announced operating results on an unaudited basis for its Q3 and nine months ended March 31, 2016, of fiscal year 2016. The Company’s Q3 highlights include Revenues of $1,141 thousand. This represents a 19.5 percent sequential increase over Q2 of fiscal 2016.
It had a Gross Margin of 24.0 percent, which was an improvement versus 22.7 percent in Q2 of fiscal 2016 and a decline versus 27.4 percent in Q3 of fiscal 2015. Moreover, Precision Optics had increased engineering/design projects, and associated revenue, utilizing its Microprecision™ optics for reusable and single-use medical devices.
Precision Optics Corp., Inc. (PEYE), closed Friday's trading session at $0.521, even for the day. The average volume for the last 60 days is 1,728 and the stock's 52-week low/high is $0.51/$0.10.
FutureLand Corp. (FUTL)
Today we are reporting on FutureLand Corp. (FUTL), here at the QualityStocks Daily Newsletter.
FutureLand Corp. is a leading provider of strategic real estate investment, grow facilities and material solutions to the worldwide cannabis industry. It is a cannabis and hemp specialty zoned land leasing enterprise. Based in Greenwood Village, Colorado, the Company concentrates on target acquisition, zoning, license fulfillment, site plan preparation and financing of cannabis or hemp grow facilities throughout the U.S. FutureLand’s shares trade on the OTCQB.
The Company leases to medical marijuana, retail marijuana and industrial hemp growers. In addition, it is in the process of owning and operating cultivation centers with a vision for dispensary and extraction facilities. FutureLand owns 240 acres in southern Colorado. Two projects are already underway there. Furthermore, the Company owns 50 percent of 78 acres in southern Oregon. There, it is implementing its first cannabis grow facility.
In essence, FutureLand gives growers the opportunity to grow. The Company monetizes by way of leasing the land, leasing the structures on the land, financing interest revenue and management fees associated with cultivation centers. FutureLand retains ownership of all the land and the structures.
The Company can provide clients with the resources and leadership through the licensing and zoning "red tape" and also site selection, sustainable development of growhouses, and first-rate equipment to ensure consistently successful grows.
In late June, FutureLand announced that it signed a Funding and consulting Agreement with HempTech Corp. (HTCO) to raise money to fund 1,000 grow pods for HempTech in association with their exclusive Master Vendor Agreement to deliver containerized grow systems (grow.droid II) for Tinkerer's Obsession Labs (TOL). TOL, together with its partners, have agreed to buy from HempTech a minimum of 1000 "grow.droid II" systems, between 2016 and 2022. This is to satisfy the increasing need for cannabis among Indian reservations in North America. The estimated contract value for the agreed upon term between HempTech and TOL is in excess of $150M.
FutureLand Corp. (FUTL), closed Friday's trading session at $0.061, down 28.24%, on 29,497 volume with 8 trades. The average volume for the last 60 days is 52,301 and the stock's 52-week low/high is $0.051/$2.50.
Bang Holdings Corp. (BXNG)
Today we are reporting on Bang Holdings Corp. (BXNG), here at the QualityStocks Daily Newsletter.
Bang Holdings Corp. is a digital advertising company headquartered in North Miami Beach, Florida. The Company provides brand management, cannabis related digital content and influencer-based marketing. It accomplishes all of this by way of its subsidiary, Bang Digital Media. Bang Holdings’ marketing networks enables companies to directly reach cannabis enthusiasts. The Company’s shares trade on the OTC Markets’ OTCQB. Bang Holdings went public in March of this year.
The Company is strategically building a digital advertising network that connects cannabis brands to consumers. Since launching its digital channel 4TwentyToday across multiple digital platforms in 2014, Bang Digital Media’s network has increased to in excess of 825,000 engaged enthusiasts. In addition, it has produced hundreds of millions of content views. The Company’s expanded network of marijuana-friendly social influencers reaches an additional 11.7 million potential customers.
Bang Holdings’ plan is to ramp up Bang Digital Media’s growth of its social network and content views. These represent the Company’s pre-revenue key performance indicator (KPI). The Company states that medicinal and/or recreational marijuana initiatives are expected to pass in a number of states this November. As a result, Bang expects to see dramatic growth in Q4 of 2016.
Additionally, Bang Digital Media is moving ahead with advances in digital technology marketing applications. At present, it is in the development of the first genuine DSI (Digital Social influencer). DSI’s can work as original characters, mascots, or spokespersons for a product. Alternatively, DSI’s can be employed to enhance the online presence of a celebrity influencer.
Bang Holdings is aggressively targeting the huge cannabis advertising void created by Google, whose restrictive advertising policies prohibit cannabis-related companies. The advertising policies of Google, and Yahoo and others, immensely restrict cannabis enterprises from advertising online. In addition, they do not permit mainstream corporations to specifically target the cannabis market.
Therefore, led by Bang Founder, Chairman and Chief Executive Officer, Mr. Steve Berke, Bang is working with an increasing network of strategic partners. They deploy a growing unit of social media influencers who are powerful audience draws, and give voice to the greater than half of all American adults who have used cannabis.
Bang Holdings Corp. (BXNG), closed Friday's trading session at $1.99, even for the day, on 50 volume with 1 trade. The average volume for the last 60 days is 1,309 and the stock's 52-week low/high is $0.99/$3.75.
Endonovo Therapeutics, Inc. (ENDV)
SeeThruEquityResearch, HEROSTOCKS, Stock Brain, SmallCapVoice, StockOnion, PennyStockProphet, SecretStockPromo, Damn Good Penny Picks, Planet Penny Stocks, Penny Pick Finders, Buzz Stocks, Stock Commander, PREPUMP STOCKS, Penny Stock Newsletter, Penny Picks, BestDamnPennyStocks, TheNextBigTrade, DSR News, and PHUB News reported on Endonovo Therapeutics, Inc. (ENDV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Endonovo Therapeutics, Inc. is a biotechnology company that lists on the OTC Markets Group’s OTCQB. It is developing bioelectronic devices and therapies for regenerative medicine. Its initial focus is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease using its ex vivo expanded and enhanced stem cells. Endonovo Therapeutics is focusing its efforts on inflammatory conditions in vital organs. The Company is based in Woodland Hills, California.
Endonovo Therapeutics’ Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo’s Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.
The purpose of the Company’s Cytotronics™ platform is to create optimized cell-based therapies with greater therapeutic potential than the un-modulated cells now being used in regenerative medicine. The underpinning for its Time-Varying Electromagnetic Field (TVEMF) technology was created at NASA in combination with the development of cell therapies to treat injuries and diseases that astronauts might encounter during long term manned missions in space.
Endonovo Therapeutics is in the pre-clinical phase of evaluating its proprietary Immunotronic technology in the treatment of chronic and acute inflammatory conditions in the liver, including fulminant liver failure. It is developing a next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord.
Endonovo previously announced a method and composition process for the creation of a cell mixture from a portion of the human umbilical cord co-cultured with adipose-derived stem cells. The resulting cell mixture provides for a rich source of highly-proliferative, immunosuppressive and non-alloreactive cells. These display neither of the major histocompatibility markers (HLA double negative). These immune privileged cells thus represent a major source of cells for allogeneic mesenchymal cell-based therapies.
This week, Endonovo Therapeutics announced it executed a binding Letter of Intent (LOI) to acquire Rio Grande Neurosciences, Inc. (RGN). RGN is a privately-held clinical stage developer of non-invasive Electroceuticals™ for the treatment of neuro-inflammation and central nervous system diseases and disorders.
This LOI is binding, however, it is subject to the execution of a definitive purchase agreement, shareholder approvals from both companies and Endonovo Therapeutics raising added capital. The parties expect to sign a definitive agreement within the third quarter ending September 30, 2016 and close at the same time or shortly afterward. Endonovo Therapeutics has paid $500,000 towards the purchase price via the issuance of a note.
Endonovo Therapeutics, Inc. (ENDV), closed Friday's trading session at $0.16, up 4.68%, on 132,092 volume with 26 trades. The average volume for the last 60 days is 166,539 and the stock's 52-week low/high is $0.052/$0.9999.
Cardax, Inc. (CDXI)
We are highlighting Cardax, Inc. (CDXI) today, here at the QualityStocks Daily Newsletter.
Cardax, Inc. is a development stage life sciences company based in Honolulu, Hawaii. The Company dedicates largely all of its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS through targeting many of the same inflammatory pathways and mediators, but with exceptional safety profiles. Cardax lists on the OTC Bulletin Board.
Cardax is preparing proprietary nature-identical products and related derivatives through total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated. This includes, but is not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease.
The Company’s initial primary emphasis is its astaxanthin technologies. Astaxanthin is a powerful and safe naturally occurring anti-inflammatory and anti-oxidant without the adverse side effects typical of anti-inflammatory treatments using steroids or NSAIDS (including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding). The safety and efficacy of Cardax’s product candidates have not been directly evaluated in clinical trials or confirmed by the Food and Drug Administration (FDA).
In 2014, Cardax and Capsugel entered into a Collaboration Agreement for the joint development of astaxanthin products for the consumer health market utilizing Capsugel’s proprietary lipid multiparticulate (LMP) formulation technology. Capsugel’s LMP technology encapsulates dissolved or suspended active ingredients into spherical lipid matrix particles. The expectation is it will increase the oral bioavailability of astaxanthin.
Moreover, BASF has exclusively licensed rights from Cardax. This is to develop and commercialize nature-identical astaxanthin in consumer health products. BASF will pay Cardax royalties on future net sales of such products. In addition, Cardax can purchase nature-identical astaxanthin from BASF for consumer health applications.
Cardax ‘s astaxanthin consumer health candidates CDX-085 and ASTX-1F have demonstrated more than two and one-half times higher oral bioavailability than a leading microalgal astaxanthin product in a head-to-head monkey study. Top-tier contract research organizations conducted the study. Bioavailability was ascertained by measuring the plasma exposure of astaxanthin over four days following a single dose.
In November 2015, Cardax announced it was awarded a U.S. patent covering the use of CDX-085 and Cardax’s other patented compounds for reduction of tissue damage associated with inflammation. Additionally, the patent protects the use of these Cardax compounds in combination with well-known anti-inflammatory treatments. This includes prednisone and other steroids and also celecoxib (Celebrex®), aspirin, naproxen, ibuprofen, and other NSAIDs. The patent was issued as United States Patent 9,180,111 on November 10, 2015. This brings the total number of issued Cardax patents to 21, with 14 in the United States and 7 internationally.
Cardax, Inc. (CDXI), closed Friday's trading session at $0.12, even for the day. The average volume for the last 60 days is 8,447 and the stock's 52-week low/high is $0.0305/$0.95.
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $1.8123, up 2.57%, on 15,317 volume with 20 trades. The stock’s average daily volume over the past 60 days is 7,773, and its 52-week low/high is $0.51/$1.976.
eXp World Holdings, Inc. today announced that it has commenced real estate brokerage operations in the State of New Jersey. The company is now operational in 43 states, Alberta, Canada, and the District of Columbia. In addition, the company is in more than 105 different Multiple Listing Services -- MLS Market areas and has more than 1400 real estate professionals, up from 862 at the beginning of the year.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp Realty Launches in New Jersey
eXp Realty Launches in Utah
Landmark Group Joins eXp Realty in Greater Boston
Moxian, Inc. (MOXCD)
The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXCD). Today, Moxian, Inc. closed trading at $7.90, up 1.28%, on 101 volume with 2 trades. The stock’s average daily volume over the past 60 days is 13, and its 52-week low/high is $6.308/$13.00.
Moxian, Inc. (MOXCD) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.
Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."
Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.
Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.
Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer
Moxian, Inc. Company Blog
Moxian, Inc. News:
Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate
Moxian, Inc. Covered by Crystal Equity Research
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.75, up 14.58%, on 45,186 volume with 66 trades. The stock’s average daily volume over the past 60 days is 6,028, and its 52-week low/high is $1.10/$5.95.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group Files Annual Report on Form 10K for Fiscal 2016
Monaker Group Shareholder Update
MissionIR Exclusive Audio Interview With Monaker Group, Inc. (MKGI) Chief Executive Officer
Cherubim Interests, Inc. (CHIT)
The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.035, up 7.69%, on 13,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 3,495, and its 52-week low/high is $0.0325/$300.00.
Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.
The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.
Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.
Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer
Cherubim Interests, Inc. Company Blog
Cherubim Interests, Inc. News:
Cherubim Interests, Inc. Announces Letter to Shareholders
Cherubim Interests, Inc. Acquires Victura Roofing and Cherubim Builders Group Oklahoma
Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.006, up 5.26%, on 447,930 volume with 23 trades. The stock’s average daily volume over the past 60 days is 2,464,472 and its 52-week low/high is $0.0057/$0.212.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Announces Plan to Restructure and Consolidate Outstanding Debt
Dominovas Energy Welcomes Project Finance Team
Dominovas Energy Launches New Hydropower Division – Currentergy
Today's Top 3
Damn Good Penny Picks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Announces Letter to Shareholders
- Dominovas Energy Corp. (DNRG) Announces Plan to Restructure and Consolidate Outstanding Debt
- eXp World Holdings, Inc. (EXPI) eXp Realty Launches in New Jersey
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives
- International Stem Cell Corp. (ISCO) Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
- Laguna Blends Inc. (LAGBF) Announces that the Clinical Trial Data of CBD Cannaceuticals Facial Serum Resulted in a 100% Overall Improvement of the Skin Appearance Within Two Weeks
- Momentous Entertainment Group, Inc. (MMEG) Outlines Aggressive Growth Business Plan
- Monaker Group, Inc. (MKGI) Shareholder Update
- Moxian, Inc. (MOXC) Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
- OurPet's Company (OPCO) Now Licensing Polymer Bonded Pet Bowl Patent
- Singlepoint, Inc. (SING) A New Audio Interview with Greg Lambrecht, CEO of SinglePoint is Now at SmallCapVoice.com
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust
- WRIT Media Group, Inc. (WRIT) Announces Development of Blockchain-Based Payment Systems